1. Home
  2. CMCM vs CCCC Comparison

CMCM vs CCCC Comparison

Compare CMCM & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCM
  • CCCC
  • Stock Information
  • Founded
  • CMCM 2009
  • CCCC 2015
  • Country
  • CMCM China
  • CCCC United States
  • Employees
  • CMCM N/A
  • CCCC N/A
  • Industry
  • CMCM Computer Software: Prepackaged Software
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCM Technology
  • CCCC Health Care
  • Exchange
  • CMCM Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • CMCM 127.6M
  • CCCC 115.0M
  • IPO Year
  • CMCM 2014
  • CCCC 2020
  • Fundamental
  • Price
  • CMCM $3.80
  • CCCC $1.47
  • Analyst Decision
  • CMCM
  • CCCC Buy
  • Analyst Count
  • CMCM 0
  • CCCC 4
  • Target Price
  • CMCM N/A
  • CCCC $12.50
  • AVG Volume (30 Days)
  • CMCM 15.7K
  • CCCC 1.3M
  • Earning Date
  • CMCM 06-06-2025
  • CCCC 05-07-2025
  • Dividend Yield
  • CMCM N/A
  • CCCC N/A
  • EPS Growth
  • CMCM N/A
  • CCCC N/A
  • EPS
  • CMCM N/A
  • CCCC N/A
  • Revenue
  • CMCM $110,544,725.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • CMCM $14.27
  • CCCC N/A
  • Revenue Next Year
  • CMCM $39.26
  • CCCC $36.31
  • P/E Ratio
  • CMCM N/A
  • CCCC N/A
  • Revenue Growth
  • CMCM 20.52
  • CCCC 98.56
  • 52 Week Low
  • CMCM $3.02
  • CCCC $1.09
  • 52 Week High
  • CMCM $6.78
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CMCM 45.39
  • CCCC 44.60
  • Support Level
  • CMCM $3.65
  • CCCC $1.42
  • Resistance Level
  • CMCM $3.90
  • CCCC $1.69
  • Average True Range (ATR)
  • CMCM 0.14
  • CCCC 0.16
  • MACD
  • CMCM 0.05
  • CCCC 0.03
  • Stochastic Oscillator
  • CMCM 42.86
  • CCCC 27.27

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: